Cofactor Genomics

Cofactor Genomics specializes in precision medicine by leveraging RNA sequencing and advanced machine learning algorithms to develop multidimensional models of disease. The company focuses on identifying powerful biomarkers that can predict patient responses to treatments, particularly in the field of immunotherapy. Operating in the biotechnology and healthcare sectors, Cofactor Genomics serves pharmaceutical companies, research institutions, and clinical laboratories. Its business model revolves around providing RNA profiling services and predictive immune modeling solutions, which are critical for developing personalized treatment plans. Revenue is generated through service contracts, clinical study collaborations, and partnerships with healthcare providers.

Keywords: RNA sequencing, precision medicine, machine learning, biomarkers, immunotherapy, predictive modeling, healthcare, biotechnology, clinical studies, personalized treatment.